TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

Search

Skyline Champion Corp

Uždarymo kaina

SektoriusVartotojų cikliškumas

66.57 2.02

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

65.17

Max

66.79

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-25M

38M

Pardavimai

-51M

594M

P/E

Sektoriaus vid.

19.015

35.993

Pelnas, tenkantis vienai akcijai

0.63

Pelno marža

6.348

Darbuotojai

9,000

EBITDA

-32M

59M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+22.87% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-08-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.1B

3.7B

Ankstesnė atidarymo kaina

64.55

Ankstesnė uždarymo kaina

66.57

Naujienos nuotaikos

By Acuity

100%

0%

353 / 373 reitingas Consumer cyclical

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Skyline Champion Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-08-04 21:42; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

2025-08-04 21:21; UTC

Uždarbis
Pagrindinės rinkos jėgos

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

2025-08-04 20:45; UTC

Uždarbis

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

2025-08-04 19:15; UTC

Pagrindinės rinkos jėgos

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

2025-08-04 23:41; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-08-04 23:41; UTC

Rinkos pokalbiai

Nikkei May Rise on Fed Stimulus Hopes

2025-08-04 23:28; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-08-04 23:28; UTC

Rinkos pokalbiai

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

2025-08-04 21:30; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025-08-04 21:21; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

2025-08-04 21:18; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

2025-08-04 20:25; UTC

Rinkos pokalbiai

India Hits Back Over Russian Oil Purchases -- Market Talk

2025-08-04 20:25; UTC

Uždarbis

Transocean 2Q Loss $938M >RIG

2025-08-04 20:25; UTC

Uždarbis

Transocean 2Q Loss/Shr $1.06 >RIG

2025-08-04 20:18; UTC

Uždarbis

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

2025-08-04 20:15; UTC

Uždarbis

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

2025-08-04 20:14; UTC

Uždarbis

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

2025-08-04 20:13; UTC

Uždarbis

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

2025-08-04 20:09; UTC

Uždarbis

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

2025-08-04 20:06; UTC

Uždarbis

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

2025-08-04 20:01; UTC

Uždarbis

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

2025-08-04 19:41; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Settle Lower -- Market Talk

2025-08-04 19:28; UTC

Rinkos pokalbiai

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

2025-08-04 19:07; UTC

Rinkos pokalbiai

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

2025-08-04 18:27; UTC

Rinkos pokalbiai

Gold Climbs on Rate Cut Speculation -- Market Talk

Akcijų palyginimas

Kainos pokytis

Skyline Champion Corp Prognozė

Kainos tikslas

By TipRanks

22.87% į viršų

12 mėnesių prognozė

Vidutinis 79.67 USD  22.87%

Aukščiausias 85 USD

Žemiausias 72 USD

Remiantis 5 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Skyline Champion Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

5 ratings

1

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

85.99 / N/APalaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Neutral Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

353 / 373 reitingas Vartotojų cikliškumas

Naujienos nuotaikos

Labai stiprus meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Skyline Champion Corp

Champion Homes, Inc. engages in the production and sale of factory-built housing in North America. The company offers manufactured and modular homes, park models recreational vehicles and cabins, accessory dwelling units, and commercial structures and modular buildings for the multi-family and hospitality sectors. It builds homes under the Skyline Homes, Champion Homes, Genesis Homes, Regional Homes, Athens Park, Dutch Housing, Atlantic Homes, Excel Homes, Homes of Merit, All American Homes, New Era, Redman Homes, ScotBilt Homes, Shore Park, Silvercrest, and Titan Homes in the United States, and Moduline and SRI Homes brand names in western Canada. The company also provides construction services to install and set-up factory-built homes; operates a factory-direct manufactured home retail business under the Regional Homes, Titan Factory Direct, and Champion Homes Center brand names; and offers transportation services to manufactured housing and other industries. The company was formerly known as Skyline Champion Corporation and changed its name to Champion Homes, Inc. in August 2024. The company was founded in 2010 and is headquartered in Troy, Michigan.